Exploring the Use of Ibogaine in Opioid Recovery: Insights from Lived Experience
Jamie Walker, Daryle Deering, Bruno Hamish Unger
Journal of Psychoactive Drugs May 22, 2026 DOI: 10.1080/02791072.2026.2673843 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative collective case study Case report Peer reviewed |
|---|---|
| Sample size | 10 |
| Population | Opioid-dependent individuals in New Zealand who used ibogaine for opioid detoxification |
| Intervention | Ibogaine |
| Topics | Addiction Ibogaine |
| Keywords | Thematic analysis Context archaeology Opioid Psychosocial Nicotine Medical prescription Clinical psychology Psychotherapist Lived experience Euphoriant Qualitative research Chronic pain |
| Key findings | Participants associated ibogaine treatment with rapid detoxification, improved mood, reduced anxiety, and periods of sustained abstinence, though relapse occurred in some cases. |
Abstract
Opioid dependence is a public health concern in New Zealand, with limited treatment options beyond opioid substitution therapy (OST). Ibogaine, a psychoactive alkaloid with reported anti-withdrawal and anti-craving effects for opioid dependence, is legally available by prescription in New Zealand, offering a context for exploring user experiences. A qualitative collective case study design was used to examine the experiences and motivations of 10 opioid-dependent individuals who used ibogaine for opioid detoxification. Participants were recruited through ibogaine networks, OST services, and snowball sampling. Semi-structured interviews were conducted and analyzed using an inductive thematic analysis approach, informed by an interpretive, experiential framework. Analysis focused on how participants understood their motivations, treatment processes, safety practices, and post-treatment outcomes. Seven themes were identified: "Desperation to be opioid free," "motivations for using ibogaine," "safety conscious and support seeking," "improving ibogaine practices," "effects of treatment on depression and anxiety," "effects of treatment on dependence," and "the spiritual effect." Participants associated ibogaine treatment with rapid detoxification, improved mood, reduced anxiety, and periods of sustained abstinence, though relapse occurred in some cases. Preparation, medical screening, and post-treatment psychosocial support were critical to positive outcomes. This study adds to the literature by documenting experiences of ibogaine use, with implications for clinical practice, policy, and future research.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Participants associated ibogaine treatment with rapid detoxification, improved mood, reduced anxiety, and periods of sustained abstinence, though relapse occurred in some cases.
Synthesized
Comparable studies
Other case reports and case series on ibogaine for addiction, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine A 31-year-old woman | 2009 | Case study | n = 1 |
| A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. 31-year-old male military veteran with moderate alcohol use disorder | 2018 | Case study | n = 1 |
| Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report. 37-year-old female with severe opioid use disorder | 2016 | Case study | n = 1 |
| Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias. 34-year-old white woman with heroin and cocaine use disorder | 2019 | Case study | n = 1 |
| Novel treatment of opioid use disorder using ibogaine and iboga in two adults Individuals with opioid use disorder accessing ibogaine through private unregulated... | 2020 | Case series | n = 2 |
Citations in the library
Cites 7
- Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American Journal of Drug and Alcohol Abuse 2018
- Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects The Journal of Nervous and Mental Disease March 1, 1995
- A systematic literature review of clinical trials and therapeutic applications of ibogaine. Journal of Substance Abuse Treatment July 1, 2022
- Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile. Toxicology and Applied Pharmacology December 1, 2013
- The adverse events of ibogaine in humans: an updated systematic review of the literature (2015-2020). Psychopharmacology June 1, 2022
and 2 more in the library